Eddie R Island
Overview
Explore the profile of Eddie R Island including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mathur G, Wilkinson M, Island E, Menitove J, Tilzer L
Vox Sang
. 2022 Jan;
117(5):738-740.
PMID: 35023153
Background And Objectives: Red blood cell (RBC) antibody levels diminish over time and negative antibody screen are commonly seen in patients with a history of antibodies. Most hospitals do not...
2.
Likhitsup A, Helzberg J, Alba L, Larkin M, Cummings L, Island E, et al.
Transplantation
. 2018 Apr;
102(8):e361.
PMID: 29688998
No abstract available.
3.
Matsumoto C, Kaufman S, Island E, Kallakury B, Yazigi N, Khan K, et al.
J Pediatr
. 2014 May;
165(1):59-64.
PMID: 24793206
Objective: To evaluate and compare the biochemical and histologic effect of parenteral fish oil lipid emulsion that is rich in omega-3 polyunsaturated fatty acids (O3FAs), Omegaven (Fresenius Kabi AG, Bad...
4.
Sivaprakasam R, Hidenori T, Pither C, Nishida S, Butler A, Island E, et al.
J Transplant
. 2013 May;
2013:202410.
PMID: 23691271
We investigated the relationship between preoperative comorbidity and postoperative survival after intestinal transplantation. Each patient received a score for preoperative comorbidity. Each comorbidity was given a score based on the...
5.
Jenkins J, Gebergzabher Y, Island E, Habashi N, Hauser G
Pediatr Transplant
. 2013 Mar;
17(3):E81-7.
PMID: 23480727
HPS is a life-threatening condition in patients with end-stage liver disease, in which intrapulmonary vascular dilatations result in intrapulmonary shunts and hypoxemia. The only successful treatment is liver transplantation. Hypoxemia...
6.
Nonsurgical care of intestinal and multivisceral transplant recipients: a review for the intensivist
Hopfner R, Tran T, Island E, McLaughlin G
J Intensive Care Med
. 2012 Jun;
28(4):215-29.
PMID: 22733723
Intestinal and multivisceral transplantation has evolved from an experimental procedure to the treatment of choice for patients with irreversible intestinal failure and serious complications related to long-term parenteral nutrition. Increased...
7.
Takahashi M, Nishida S, Panthaki Z, Fan J, Romano A, Tekin A, et al.
Liver Transpl
. 2012 Jun;
18(9):1121-3.
PMID: 22685071
No abstract available.
8.
Tsai H, Island E, Chang J, Gonzalez-Pinto I, Tryphonopoulos P, Nishida S, et al.
Transplantation
. 2011 Aug;
92(6):709-15.
PMID: 21804443
Background: Donor-specific antibodies (DSA) are associated with acute kidney graft rejection, but their role in small bowel/multivisceral allograft remains unclear. We carried out a prospective study to understand the impact...
9.
Asaoka T, Island E, Tryphonopoulos P, Selvaggi G, Moon J, Tekin A, et al.
Transpl Int
. 2011 May;
24(7):697-707.
PMID: 21557779
Small bowel transplantation (SBT) is becoming a preferred treatment for patients with irreversible intestinal failure. Despite continuous improvement of immunosuppression, SBT is plagued by a high incidence of acute cellular...
10.
Island E, Gonzalez-Pinto I, Tsai H, Ruiz P, Tryphonopoulos P, Gonzalez M, et al.
Clin Transpl
. 2010 Jun;
:465-9.
PMID: 20524316
Graft rejection is a serious complication after intestinal and multivisceral transplantation. Classic anti-rejection strategies often focus on addressing the cellular component, however mounting evidence suggests that antibody mediated rejection may...